Literature DB >> 8791180

The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample.

B F Grant1, D S Hasin, D A Dawson.   

Abstract

This study examined the primary-secondary distinction with respect to DSM-IV alcohol use disorders and major depression in a large representative sample of the USA. Primary, secondary and concurrent depressives (i.e. the comorbid groups), respondents classified with major depression only and respondents classified with alcohol use disorders only were compared on a large number of sociodemographic, alcohol-related, depression-related and drug-related variables. Results were at variance with a majority of findings from the treatment literature with regard to familial aggregation of alcohol use disorders and sociodemographic, alcohol and depression profiles. Implications of the results are discussed in terms of the diagnostic and prognostic significance of the primary-secondary distinction.

Entities:  

Mesh:

Year:  1996        PMID: 8791180     DOI: 10.1016/0165-0327(96)00002-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  17 in total

1.  Energy drink consumption and increased risk for alcohol dependence.

Authors:  Amelia M Arria; Kimberly M Caldeira; Sarah J Kasperski; Kathryn B Vincent; Roland R Griffiths; Kevin E O'Grady
Journal:  Alcohol Clin Exp Res       Date:  2010-11-12       Impact factor: 3.455

Review 2.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature.

Authors:  Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele
Journal:  Drug Alcohol Depend       Date:  2006-06-08       Impact factor: 4.492

3.  Pretreatment clinical and risk correlates of substance use disorder patients with primary depression.

Authors:  Amy M Cohn; Elizabeth E Epstein; Barbara S McCrady; Noelle Jensen; Dorian Hunter-Reel; Kelly E Green; Michelle L Drapkin
Journal:  J Stud Alcohol Drugs       Date:  2011-01       Impact factor: 2.582

4.  Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study.

Authors:  K M Carpenter; D S Hasin; D B Allison; M S Faith
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

Review 5.  Gender differences in factors influencing alcohol use and drinking progression among adolescents.

Authors:  Marya T Schulte; Danielle Ramo; Sandra A Brown
Journal:  Clin Psychol Rev       Date:  2009-06-11

6.  Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders.

Authors:  Daniel E Falk; Hsiao-Ye Yi; Michael E Hilton
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

7.  Mood-related drinking motives mediate the familial association between major depression and alcohol dependence.

Authors:  Kelly C Young-Wolff; Kenneth S Kendler; Nicole D Sintov; Carol A Prescott
Journal:  Alcohol Clin Exp Res       Date:  2009-05-04       Impact factor: 3.455

8.  Racial/ethnic disparities in service utilization for individuals with co-occurring mental health and substance use disorders in the general population: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Mark L Hatzenbuehler; Katherine M Keyes; William E Narrow; Bridget F Grant; Deborah S Hasin
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

9.  Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains.

Authors:  Bruk Getachew; Sheketha R Hauser; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2008-06-29       Impact factor: 3.533

10.  Comorbidity between major depression and alcohol use disorder from adolescence to adulthood.

Authors:  Frédéric N Brière; Paul Rohde; John R Seeley; Daniel Klein; Peter M Lewinsohn
Journal:  Compr Psychiatry       Date:  2013-10-22       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.